APA (7th ed.) Citation

Aerts, J. G. J. V., Burg, S. H. v. d., Lolkema, M. P., Lau, S. P., Land, F. R. v. ’., Homs, M. Y. V., & Eijck, C. H. J. v. Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: Protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial). BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Aerts, Joachim G J V., Sjoerd H van der Burg, Martijn P. Lolkema, Sai Ping Lau, Freek R van ’t Land, Marjolein Y V. Homs, and Casper H J van Eijck. Safety and Tumour-specific Immunological Responses of Combined Dendritic Cell Vaccination and Anti-CD40 Agonistic Antibody Treatment for Patients with Metastatic Pancreatic Cancer: Protocol for a Phase I, Open-label, Single-arm, Dose-escalation Study (REACtiVe-2 Trial). BMJ Publishing Group.

MLA (9th ed.) Citation

Aerts, Joachim G J V., et al. Safety and Tumour-specific Immunological Responses of Combined Dendritic Cell Vaccination and Anti-CD40 Agonistic Antibody Treatment for Patients with Metastatic Pancreatic Cancer: Protocol for a Phase I, Open-label, Single-arm, Dose-escalation Study (REACtiVe-2 Trial). BMJ Publishing Group.